Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
A JoncourM PuyadeA MichaudJ-M TouraniF Cazenave-RoblotBlandine RammaertPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)
Outcome of BSI is favorable in low-risk febrile neutropenic patients, even with inappropriate empirical initial antibiotic regimen for coagulase-negative Staphylococcus BSI. Initial in-hospital assessment and close monitoring of these patients are however mandatory.